June 19-21, 2013,
The Revere Hotel, Boston, MA
http://www.healthtech.com/sbd/

At CHI/Bio-IT World's thirteenth annual Structure-Based Drug Design
conference, you will hear about developments in insilico technology, as
well as experimental approaches useful for accurately predicting and
modeling the structures of proteins in structure-based drug design
efforts. In addition, examples of successful applications of such
technology approaches to genome-to-drug lead investigations will be
addressed.

KEYNOTE PRESENTATION:

Drugging the Undruggable:
Transforming Nature's α-Helix into Breakthrough Medicines
Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics

Exploiting Solvent Effects in Drug Design and Optimization
Christopher R. Corbeil, Ph.D., Research Scientist, Chemical Computing Group

Determination of Binding Poses, Kinetics and Energetics in Fragment-Based
Design
Gianni De Fabritiis, Ph.D., Computational Biophysics Laboratory (GRIB-IMIM),
Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB)

Visually Informed, Interactive Lead Optimization
Carsten Detering, Ph.D., CEO, BioSolveIT

Case Histories of Recent Fragment-Based Drug Discovery Projects
Christopher Murray, Ph.D., Director, VP Discovery Technology,
Astex Pharmaceuticals

Incorporating Ligand Polarisation in Binding Free Energy Calculations
Jonathan W. Essex, Ph.D., Head, Computational Systems Chemistry, Chairman,
Institute for Complex Systems Simulation (ICSS), School of Chemistry,
University of Southampton

Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!